1 INTRODUCTION    
    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

 
2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Research Design
    2.3 Secondary and Primary Research Methodology
           2.3.1 Secondary Research
                    2.3.1.1 Key Data From Secondary Sources
           2.3.2 Primary Research
                    2.3.2.1 Key Data From Primary Sources
           2.3.3 Market Size Estimation Methodology
    2.4 Opportunity Indicators
           2.4.1 Demand-Side Analysis
                    2.4.1.1 Incidence and Prevalence of Cancer
                    2.4.1.2 Rapid Growth of Geriatric Population
                    2.4.1.3 Significant Number of Clinical Researches in Ablation
           2.4.2 Supply-Side Analysis
                    2.4.2.1 Clinical Trials By Ablation Technology
                    2.4.2.2 Number of New Product Launches: Ablation Market (2013–2016)
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights
    4.1 Global Ablation Technology Market Overview
    4.2 Geographical Snapshot of the Global Ablation Technology Market
    4.3 Global Ablation Technology Market, By Type and Region
    4.4 Global Ablation Technology Market, By Application
    4.5 Global Ablation Technology Market Size, By Product (2016 vs 2021)

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Emergence of Next-Generation Ablation Products and Technology
                    5.2.1.2 Rising Incidence of Cancer
                    5.2.1.3 Growing Prevalence of Cardiovascular Diseases
                    5.2.1.4 Increasing Number of Ablation Procedures
                    5.2.1.5 Increasing Number of Hospitals, Surgical, and Ablation Centers
           5.2.2 Restraints
                    5.2.2.1 Reuse and Reprocessing of Devices in Developing Countries
                    5.2.2.2 Healthcare Cost-Containment Measures
                    5.2.2.3 Unfavorable Regulatory Scenario
           5.2.3 Opportunities
                    5.2.3.1 Growth Potential Offered By Emerging Markets
                    5.2.3.2 Rising Awareness Related to Ablation Procedures
           5.2.4 Challenges
                    5.2.4.1 Product Recalls
                    5.2.4.2 Therapeutic Challenges

6 Industry Trends
    6.1 Key Industry Trends: Ablation Market
           6.1.1 Industry Consolidation
           6.1.2 Increasing Focus of Global Players Towards Developing Nations
           6.1.3 Increasing Funding for Ablation Product Development and Commercialization
           6.1.4 Notable Developments in Microwave Ablation Segment
           6.1.5 High Focus of Market Players Towards Development of Advanced Radiofrequency Ablation Devices
    6.2 Reimbursement Scenario (Qualitative Insights)
    6.3 Supply Chain Analysis
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Global Ablation Technology Market, By Type
    7.1 Introduction
    7.2 Radiofrequency Ablation
    7.3 Laser/Light Ablation
    7.4 Ultrasound Ablation
    7.5 Electrical Ablation
    7.6 Cryoablation
    7.7 Microwave Ablation
    7.8 Hydrothermal Ablation

8 Global Ablation Technology Market, By Product
    8.1 Introduction
    8.2 Radiofrequency Ablators
           8.2.1 Temperature-Controlled Radiofrequency Ablators
           8.2.2 Fluid-Cooled Radiofrequency Ablators
           8.2.3 Robotic Catheter Manipulation Systems
    8.3 Laser/Light Ablators
           8.3.1 Excimer Laser Ablators
           8.3.2 Cold Laser Ablators
    8.4 Ultrasound Ablators
           8.4.1 Ultrasonic Surgical Ablation Systems
           8.4.2 High-Intensity Focused Ultrasound (HIFU) Ablators
           8.4.3 Extracorporeal Shockwave Lithotripsy (ESWL) Systems
           8.4.4 Magnetic Resonance-Guided Focused Ultrasound (MRGFUS) Ablators
    8.5 Electrical Ablators
           8.5.1 Argon Plasma/Beam Coagulators
           8.5.2 Irreversible Electroporation Ablators
    8.6 Cryoablation Devices
           8.6.1 Tissue Contact Probes
           8.6.2 Tissue Spray Probes
           8.6.3 Epidermal and Subcutaneous Cryoablation Devices
    8.7 Microwave Ablators
           8.7.1 Microwave Thermotherapy Devices
    8.8 Hydrothermal Ablators
           8.8.1 Endometrial Hydrothermal Balloon Ablation Devices

9 Global Ablation Technology Market, By Application
    9.1 Introduction
    9.2 Cardiovascular Disease Treatment
    9.3 Cancer Treatment
           9.3.1 Liver Cancer
           9.3.2 Kidney Cancer
           9.3.3 Prostate Cancer
           9.3.4 Lung Cancer
           9.3.5 Bone Metastasis
           9.3.6 Breast Cancer
    9.4 Ophthalmologic Treatment
    9.5 Pain Management
    9.6 Gynecological Treatment
    9.7 Urological Treatment
    9.8 Orthopedic Treatment
    9.9 Cosmetic/ Aesthetic Surgery
    9.10 Other Treatments

10 Global Ablation Technology Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Significant Volume of Ablation Procedures in the Country
                        10.2.1.2 Remarkable Adoption of Advanced Ablation Technology as Compared to Conventional Technology
                        10.2.1.3 Availability of Funding for Development of Novel Ablation Devices
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Rising Focus of Market Players
                        10.3.1.2 Large Number of Ongoing Clinical Trials
                        10.3.1.3 Favorable Healthcare Reimbursement Scenario
                        10.3.1.4 Growing Incidence of Cancer and Cardiovascular Diseases
             10.3.2 France
                        10.3.2.1 Availability of Funding for Development of Novel Ablation Devices in the Country
                        10.3.2.2 Availability of Training Programs and Reimbursement for Certain Products in France
             10.3.3 U.K.
                        10.3.3.1 Large Patient Population Base
                        10.3.3.2 Availability of Research Funding
                        10.3.3.3 Expanding Presence of Market Players
                        10.3.3.4 Government Recommendations Encouraging Adoption of Ablation Technology
             10.3.4 Rest of Europe
                        10.3.4.1 Rapidly Increasing Aging Population in the Region
                        10.3.4.2 Increasing Market Penetration of Leading Ablation Manufacturers in the Region
                        10.3.4.3 Prominent Adoption of Ablation in Italy
     10.4 Asia-Pacific
             10.4.1 Increasing Government Initiatives in the Region
                        10.4.1.1 Awareness Programs and Conferences in APAC
                        10.4.1.2 Rising Focus of Market Players
             10.4.2 Japan
                        10.4.2.1 Well-Developed Healthcare System
                        10.4.2.2 Rising Baby Boomer Population Coupled With Cancer Incidence in the Country
                        10.4.2.3 Rising Government Focus Towards the Development of the Medical Device Industry
             10.4.3 China
                        10.4.3.1 High Incidence of Target Diseases and Rapidly Aging Population
             10.4.4 India
                        10.4.4.1 Remarkable Patient Base in the Country
                        10.4.4.2 Improving Healthcare Infrastructure in the Country
                        10.4.4.3 Rising Focus of Global Players
             10.4.5 Rest of Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches & Approvals
             11.3.2 Mergers & Acquisitions
             11.3.3 Geographical Expansions
             11.3.4 Agreements and Joint Ventures
             11.3.5 Other Developments

12 Company Profiles
     12.1 Introduction
     12.2 Medtronic PLC
     12.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
     12.4 St. Jude Medical, Inc.
     12.5 Boston Scientific Corporation
     12.6 Angiodynamics, Inc.
     12.7 Atricure, Inc.
     12.8 Conmed Corporation
     12.9 Olympus Corporation
     12.10 Smith & Nephew
     12.11 Galil Medical Inc. (Acquired By BTG International Ltd.)